Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerard F Anderson

Showing results (161-170 of 167) with videos related to

Pageof 17
Sort By:
You have reached the last page of results.This site can display upto 167 results.
Cureus|November 18, 2025
Trends in Research Payments From Industry to DermatologistsCraig Cronin, Aleksandra Drmanovic, Zeyad Hammadeh, et al.
Health Affairs (Project Hope)|March 12, 2008
Health insurance coverage in Central and Eastern Europe: trends and challengesHugh R Waters, Jessica Hobart, Christopher B Forrest, et al.
Health Services Research|September 15, 2015
Evaluating Clinical Practice Guidelines Based on Their Association with Return to Work in Administrative Claims DataEric T Roberts, Eva H DuGoff, Sara E Heins, et al.
Journal of Clinical Medicine|November 11, 2020
Pioglitazone Is Associated with Lower Major Adverse Cardiovascular and Cerebrovascular Events than DPP4-Inhibitors in Diabetic Patients with End-Stage Renal Disease: A Taiwan Nationwide Cohort Study, 2006-2016Min-Hao Lin, Huang-Yu Yang, Chieh-Li Yen, et al.
Diabetes Care|August 18, 2020
Pioglitazone Reduces Mortality and Adverse Events in Patients With Type 2 Diabetes and With Advanced Chronic Kidney Disease: National Cohort StudyChieh-Li Yen, Chao-Yi Wu, Lai-Chu See, et al.
Frontiers in Medicine|February 17, 2022
Reduced Risk of Sepsis and Related Mortality in Chronic Kidney Disease Patients on Xanthine Oxidase Inhibitors: A National Cohort StudyHuang-Yu Yang, Yun-Shiuan Olivia Hsu, Tao Han Lee, et al.
Clinical Pharmacology and Therapeutics|October 20, 2019
Comparative Renoprotective Effect of Febuxostat and Allopurinol in Predialysis Stage 5 Chronic Kidney Disease Patients: A Nationwide Database AnalysisYun-Shiuan O Hsu, I-Wen Wu, Shang-Hung Chang, et al.
Pageof 17

Showing results (161-170 of 167) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 167 results.
Cureus|November 18, 2025
Trends in Research Payments From Industry to DermatologistsCraig Cronin, Aleksandra Drmanovic, Zeyad Hammadeh, et al.
Health Affairs (Project Hope)|March 12, 2008
Health insurance coverage in Central and Eastern Europe: trends and challengesHugh R Waters, Jessica Hobart, Christopher B Forrest, et al.
Health Services Research|September 15, 2015
Evaluating Clinical Practice Guidelines Based on Their Association with Return to Work in Administrative Claims DataEric T Roberts, Eva H DuGoff, Sara E Heins, et al.
Journal of Clinical Medicine|November 11, 2020
Pioglitazone Is Associated with Lower Major Adverse Cardiovascular and Cerebrovascular Events than DPP4-Inhibitors in Diabetic Patients with End-Stage Renal Disease: A Taiwan Nationwide Cohort Study, 2006-2016Min-Hao Lin, Huang-Yu Yang, Chieh-Li Yen, et al.
Diabetes Care|August 18, 2020
Pioglitazone Reduces Mortality and Adverse Events in Patients With Type 2 Diabetes and With Advanced Chronic Kidney Disease: National Cohort StudyChieh-Li Yen, Chao-Yi Wu, Lai-Chu See, et al.
Frontiers in Medicine|February 17, 2022
Reduced Risk of Sepsis and Related Mortality in Chronic Kidney Disease Patients on Xanthine Oxidase Inhibitors: A National Cohort StudyHuang-Yu Yang, Yun-Shiuan Olivia Hsu, Tao Han Lee, et al.
Clinical Pharmacology and Therapeutics|October 20, 2019
Comparative Renoprotective Effect of Febuxostat and Allopurinol in Predialysis Stage 5 Chronic Kidney Disease Patients: A Nationwide Database AnalysisYun-Shiuan O Hsu, I-Wen Wu, Shang-Hung Chang, et al.
Pageof 17